Nordic Pharma Limited

Nordic Pharma Limited, based in Theale, UK, is a small, holding company with an active status, celebrating 45 years since its founding in 1980. Employing 20 people and holding £4,612,601 in assets, the company operates from a real address and is overseen by four directors and two owners. It’s a regular importer of pharmaceutical products, with 7 months of import activity recorded, and a regular exporter of optical and medical tools and devices, with 9 months of export activity.

The company’s website, while not providing detailed operational specifics, suggests a focus on wholesale pharmaceutical goods. It’s a fairly standard business model, and it's likely that Nordic Pharma operates as a distributor, sourcing products from manufacturers and supplying them to pharmacies, hospitals, or other healthcare providers. It’s not clear if they have their own e-commerce presence or primarily operate through business-to-business channels.

Financially, Nordic Pharma Limited presents a mixed picture. While turnover is not explicitly stated, the company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) suggests it's a modest operation. However, the financial data reveals some concerning trends. Net assets have plummeted by a staggering 91%, falling to just £32,000, and retained earnings have swung into a substantial loss of -£170,000. Bank borrowings have increased significantly, rising by 21% to £1,300,000, and creditors have ballooned by 130% to £4,400,000. While trade debtors have increased by 34%, it’s possible this is a result of expanding sales, but it also could indicate difficulties in collecting payments. Cash reserves are minimal, sitting at just £140.

The surge in creditors and bank borrowings, coupled with the significant loss, suggests that Nordic Pharma is burning through cash and facing liquidity pressures. The company’s reliance on group undertakings, with £1,700,000 owed to them, highlights its dependence on external funding. The increase in average employees during the period, from 20 to 29, may be a sign of growth, but it also adds to the company’s expenses. The fact that the company has elected not to include a copy of the income statement within the financial statements is not unusual for small companies. The audit firm, Rice Associates Limited, has provided an unqualified opinion, but the underlying financial health remains a concern. The company's past name, Nordic Pharmaceuticals Limited, suggests a possible rebranding effort.

Registered in England/Wales under the registration number 01489084, with a registered address at RG7 4SA, United Kingdom, Theale, Reading, Building 1410 Arlington Business Park.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.